Stuart L. Goldberg

Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy

Andreas Hochhaus, Hagop M. Kantarjian, Michele Baccarani et al. · Blood · 2006 · 607 citations · Full text

Phase I Trial of Intravenous Administration of PV701, an Oncolytic Virus, in Patients With Advanced Solid Cancers

Andrew L. Pecora, Naiyer A. Rizvi, Gary I. Cohen et al. · Journal of Clinical Oncology · 2002 · 386 citations

BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive Leukemia

Matthew S. Zabriskie, Christopher A. Eide, Srinivas K. Tantravahi et al. · Cancer Cell · 2014 · 363 citations · Full text

Hematological Malignancy, Ph Chromosome-positive Leukemia, Genetics +7

Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib

Andreas Hochhaus, Michele Baccarani, Michael W. Deininger et al. · Leukemia · 2008 · 352 citations

Chronic Phase, Hematological Malignancy, Immunology +8

Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study

Noa Biran, Andrew Ip, Jaeil Ahn et al. · The Lancet Rheumatology · 2020 · 294 citations · Full text

Long Covid, Intensive Care Unit, Multicentre Observational Study +7